These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 28106477)

  • 1. Thymosin alpha 1 and HIV-1: recent advances and future perspectives.
    Matteucci C; Grelli S; Balestrieri E; Minutolo A; Argaw-Denboba A; Macchi B; Sinibaldi-Vallebona P; Perno CF; Mastino A; Garaci E
    Future Microbiol; 2017 Feb; 12():141-155. PubMed ID: 28106477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy.
    Chadwick D; Pido-Lopez J; Pires A; Imami N; Gotch F; Villacian JS; Ravindran S; Paton NI
    Clin Exp Immunol; 2003 Dec; 134(3):477-81. PubMed ID: 14632754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro.
    Matteucci C; Minutolo A; Pollicita M; Balestrieri E; Grelli S; D'Ettorre G; Vullo V; Bucci I; Luchini A; Aquaro S; Sinibaldi-Vallebona P; Macchi B; Perno CF; Mastino A; Garaci E
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S83-100. PubMed ID: 26094546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
    D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
    J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.
    Resino S; Galán I; Pérez A; León JA; Seoane E; Gurbindo D; Muñoz-Fernandez MA
    Clin Exp Immunol; 2004 Sep; 137(3):570-7. PubMed ID: 15320908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T Cells.
    Jensen SS; Fomsgaard A; Larsen TK; Tingstedt JL; Gerstoft J; Kronborg G; Pedersen C; Karlsson I
    PLoS One; 2015; 10(10):e0139573. PubMed ID: 26426913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.
    Matteucci C; Minutolo A; Sinibaldi-Vallebona P; Palamara AT; Rasi G; Mastino A; Garaci E
    Ann N Y Acad Sci; 2010 Apr; 1194():6-19. PubMed ID: 20536445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of prothymosin-alpha on HIV-1 target cells.
    Mosoian A; Teixeira A; Burns CS; Khitrov G; Zhang W; Gusella L; Klotman P; Klotman M
    Ann N Y Acad Sci; 2007 Sep; 1112():269-85. PubMed ID: 17600282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy.
    Li T; Wu N; Dai Y; Qiu Z; Han Y; Xie J; Zhu T; Li Y
    Clin Infect Dis; 2011 Nov; 53(9):944-51. PubMed ID: 21960716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function.
    Vecchi M; Burighel N; Bellanova D; Menzo S; De Rossi A; Clementi M; Bagnarelli P
    New Microbiol; 2004 Apr; 27(2 Suppl 1):99-104. PubMed ID: 15646071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.
    Freeman ML; Lederman MM; Gianella S
    Curr HIV/AIDS Rep; 2016 Feb; 13(1):10-9. PubMed ID: 26810437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under different highly active antiretroviral therapy regimens.
    Atzori C; Clerici M; Trabattoni D; Fantoni G; Valerio A; Tronconi E; Cargnel A
    J Antimicrob Chemother; 2003 Aug; 52(2):276-81. PubMed ID: 12837736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment interruptions in HIV-infected subjects.
    Bongiovanni M; Casana M; Tincati C; d'Arminio Monforte A
    J Antimicrob Chemother; 2006 Sep; 58(3):502-5. PubMed ID: 16816398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, Immune Activation, and Antiretroviral Therapy in HIV.
    Hileman CO; Funderburg NT
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):93-100. PubMed ID: 28434169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
    Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
    HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.